These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 1323814)

  • 1. Platinum/oral etoposide therapy in non-small cell lung cancer.
    Furuse K
    Oncology; 1992; 49 Suppl 1():63-9; discussion 70. PubMed ID: 1323814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancer.
    Greco FA; Murphy PB; Hainsworth JD; Hande KR; Johnson DH
    Oncology; 1992; 49 Suppl 1():34-8; discussion 39. PubMed ID: 1323810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of weekly high-dose cisplatin combined with oral etoposide in advanced non-small-cell lung cancer.
    Planting A; Kho S; van der Burg M; Goey H; Schellens J; van den Bent M; van der Gaast A; de Boer-Dennert M; Stoter G; Verweij J
    Cancer Chemother Pharmacol; 1997; 40(4):347-52. PubMed ID: 9225954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
    Johnson FM; Kurie JM; Peeples BO; Lee JJ; Feng L; Pisters KM; Fossella FV; Papadimitrakopoulou VA; Blumenschein GR; Komaki R; Glisson BS
    Clin Lung Cancer; 2003 Jul; 5(1):40-5. PubMed ID: 14596703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancer.
    Fukuoka M; Masuda N; Negoro S; Takada M; Kudoh S; Kusunoki Y; Matsui K; Takifuji N; Tachikawa A; Kawahara M
    Cancer; 1991 Jul; 68(2):284-8. PubMed ID: 2070326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of paclitaxel and oral etoposide in previously untreated non-small-cell and extensive small-cell lung cancer.
    Boyer MJ; Zalcberg J; Olver IN; Millward MJ; Richardson G; McKeage MJ
    Ann Oncol; 1997 May; 8(5):485-9. PubMed ID: 9233529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of cisplatin and prolonged administration of oral etoposide in extensive-stage small cell lung cancer.
    Murphy PB; Hainsworth JD; Greco FA; Hande KR; DeVore RF; Johnson DH
    Cancer; 1992 Jan; 69(2):370-5. PubMed ID: 1309432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
    Chang AY; Kim K; Boucher H; Bonomi P; Stewart JA; Karp DD; Blum RH
    Cancer; 1998 Jan; 82(2):292-300. PubMed ID: 9445185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.
    Bonomi P; Kim K; Fairclough D; Cella D; Kugler J; Rowinsky E; Jiroutek M; Johnson D
    J Clin Oncol; 2000 Feb; 18(3):623-31. PubMed ID: 10653877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pilot phase II trial of high-dose etoposide combined with cisplatin in the treatment of refractory lung cancer].
    Fujita J; Morikawa N; Yamaji Y; Kubo A; Takigawa K; Yamagishi Y; Fujita T; Shiotani T; Takahara J; Irino S
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):849-54. PubMed ID: 1318697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer.
    Greco FA; Stroup SL; Gray JR; Hainsworth JD
    J Clin Oncol; 1996 May; 14(5):1642-8. PubMed ID: 8622083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of unresectable non-small cell lung cancer (NSCLC) with carboplatin and chronic daily administration of oral etoposide].
    Hirabayashi M; Tanaka Y; Yoshida H; Nakagawa M; Kuno K
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):53-8. PubMed ID: 8291916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
    Masuda N; Fukuoka M; Kudoh S; Matsui K; Kusunoki Y; Takada M; Nakagawa K; Hirashima T; Tsukada H; Yana T
    J Clin Oncol; 1994 Sep; 12(9):1833-41. PubMed ID: 7521905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory combination chemotherapy with oral etoposide and cisplatin for advanced non small cell lung carcinoma patients. A phase II study.
    Focan C; Le Hung S; Frere MH; Schallier D
    Anticancer Res; 1986; 6(5):977-81. PubMed ID: 3026238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
    Mok TS; Wong H; Zee B; Yu KH; Leung TW; Lee TW; Yim A; Chan AT; Yeo W; Chak K; Johnson P
    Cancer; 2002 Oct; 95(7):1511-9. PubMed ID: 12237920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer.
    Bunn PA; Kelly K
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-144-S12-148. PubMed ID: 9331140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboplatin plus oral etoposide in the management of unresectable non-small cell lung cancer. Preliminary results of a Vanderbilt trial.
    Johnson DH; Hainsworth JD; DeVore R; Hande KR; Greco FA
    Oncology; 1992; 49 Suppl 1():57-61; discussion 61-2. PubMed ID: 1323813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.